Australia markets close in 3 hours 2 minutes

Zealand Pharma A/S (22Z.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
43.64-0.76 (-1.71%)
At close: 08:36AM CET
Full screen
Previous close44.40
Open43.64
Bid44.98 x 60000
Ask46.34 x 60000
Day's range43.64 - 43.64
52-week range25.58 - 44.40
Volume50
Avg. volume8
Market cap2.545B
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
EPS (TTM)-1.91
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est222.65
  • GlobeNewswire

    Zealand Pharma to highlight obesity pipeline at R&D Event on December 5

    Press release – No. 16 / 2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5 Event to be hosted by company management and feature key external scientific and clinical experts Copenhagen, Denmark, December 4, 2023 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines is hosting an Obesity R&D Event in London on Tuesday, December 5th (1:3

  • GlobeNewswire

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    Company announcement – No. 42 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, December 4, 2023 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securi

  • GlobeNewswire

    Total number of shares and voting rights in Zealand Pharma at November 30, 2023

    Company announcement – No. 41 / 2023 Total number of shares and voting rights in Zealand Pharma at November 30, 2023 Copenhagen, Denmark, November 30, 2023 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a c